Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
The Society for Immunotherapy of Cancer is partnering with The Cancer Drug ... GBM is the most aggressive and lethal form of brain cancer, and is an ...
The discovery of this mechanism highlights a new avenue for cancer immunotherapy—using soluble ligands to restore antitumour immunity.
Dendreon's prostate cancer immunotherapy Provenge is now being backed by IQWiG just months after the German health technology assessor was ...
Sipuleucel-T Found to Have Added Therapeutic Benefit in Prostate Cancer Patients -Prostate Cancer News Today
Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company's DepoVax(TM) platform, a patented ...
A triple attack of radiation plus two immunotherapies appears to improve ... The immune system uses T cells, which are immune cells, to fight cancer ...
Despite advances in combinatorial chemotherapy regimens and the advent of intraperitoneal chemotherapy administration, current therapeutic ...
Bristol-Myers' cancer medicine Opdivo tops the list, with projected 2019 ... from the immune system, allowing it to recognize and attack cancer cells.
... a privately-held company focused on cancer immunotherapy and cancer ... that harness the body's own immune system in the fight against cancer.
Scientists have found that genetic changes in bowel tumors are linked to the way the body's immune system responds to the cancer, according to ...
New potential for personalised treatments in bowel cancer - AnaesthesiaUK
Bowel cancer breakthrough hailed - World First Travel Insurance
High levels of hazardous substances, including the cancer-causing ... excessive bleeding and a reduction in the capacity of the immune system to fight ...
British figures still well below other countries despite billions being spent to improve situation over the last 15 years
Cancer survival rates more than 10 years behind other European countries
Breast cancer survival rates in UK below those achieved by others in 1990s
Figures despite Britain spending billions to improve situation last 15 years
Macmillan said it was ‘shameful’ and proves better rates not unachievable
More than 3,000 cases of cervical cancer are diagnosed each year in UK
New technology requires neither a biopsy nor a smear test
Cancerous tissue can be picked up on an ultrasound scan because of laser
Colon cancer is one of the most common cancers in the UK and rates are rising. Julia Lonsdale, 65, a retired nurse, underwent a new procedure to remove her tumour, leaving no visible scar
Terry Wheeldon noticed a red blister on his stomach after using a sunbed
It was the first sign of a malignant melanoma — a deadly skin cancer
His blister never went away, and it slowly turned into a small brown mole
He went back to the doctor on several occasions, but was told it was fine
Mole started to itch and a biopsy revealed it was a malignant melanoma
Four years later, a CT scan found seven small tumours near Terry's lungs
(Nanowerk News) Scientists at UCLA's California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their ...
The latest report Pancreatic Cancer Pipeline Highlights - 2015, provides most up-to-date information on key pipeline molecules in the global ...
Along with breast cancer, Skala and her team have also started testing the organoids derived from pancreatic cancer patients. If further trials prove ...
Tumors grown in dishes could help customize cancer treatment - WHBL Sheboygan
Pancreatic cancer, a devastating disease with a five-year survival rate of 5 percent, is difficult to detect early and symptoms do not usually appear until ...
This protein is found in some aggressive cancers and plays a role in the ... of these cancers in the brain, breast, kidneys, liver, lungs and pancreas.
They also infer that patients with pancreatic cancers and some lung cancers may benefit from this drug combination therapy, as the RAS oncogene is ...
United Against Cancer, 08-10 June 2015, Belfast
Patients who received chemotherapy after bladder cancer surgery demonstrated an approximately 30% lower risk of death than those who underwent ...
Failure to identify all of the superficial lesions present in patients undergoing transurethral resection is a common problem, which can lead to bladder ...
BCG is a prototypal cancer immunotherapeutic factor currently approved of bladder cancer. In attempt to further enhance the effectiveness of ...
MADRID, SPAIN (UroToday.com) - Level I evidence exists about the role of neoadjuvant chemotherapy for muscle-invasive bladder cancer for an ...
#EAU15 - Neoadjuvant cisplatinum-based chemotherapy does not impact perioperative morbidity ... -UroToday
Bladder cancer affects more than 54,000 men and 17,000 women in the United States annually, making it the fourth most common cancer among men ...
... tested as treatment for other tumor types, including gastric, head and neck, bladder cancer, triple negative breast cancer, and Hodgkin's Lymphoma.
Saccharin was labeled a possible carcinogen after studies in the 1970s linked it to bladder cancer in laboratory rats. However later studies found the ...
Saccharin Shows Superb Promise as Aggressive Cancer Treatment - Modern Readers
In 2012, Dr. Solit and his co-workers published a groundbreaking study of a patient with advanced bladder cancer who participated in a clinical trial of ...
An application for the first clinical trial with VPM1002BC for the treatment of nonmuscle invasive bladder cancer was submitted in December 2014.
Vitamin D directly effects prostate cancer cells
Unregulated copies of Pomi-T are hitting UK websites
Saunas are good for men!
Sugar lowering drug helps men with prostate cancer
Quitting smoking improve outcomes after prostate cancer
Science Daily Cancer News
The concept was simple: if two compounds each individually show promise in preventing colon cancer, surely it's worth trying the two together to see if even greater impact is possible. Not only did the combination of the two improve outcomes in animal studies, but the dual-compound effect was dramatically better than either option alone.
Cancer research breakthrough: Immune markers discovered that can predict ovarian cancer patients' response to treatment
A biomarker that will help lead to better predictions of the success of chemotherapy in ovarian cancer patients has been discovered by researchers. This discovery could lead to better treatment options in the fight against ovarian cancer, they say.
Diabetes is associated with more advanced stage breast cancer, according to a new study that confirms a strong link between diabetes and later stage breast cancer at diagnosis. "Our findings suggest that women with diabetes may be predisposed to more advanced stage breast cancer, which may be a contributor to their higher cancer mortality," said one scientist.
The link between aspirin and colon cancer prevention may depend on a person's individual genetics, scientists report. "We've known for a long time that aspirin lowers the risk of bowel cancer, but we also know that not everyone gets the same degree of protection," said a co-author of a new paper.
It is possible to detect endometrial cancer using tumor DNA picked up by ordinary tampons, researchers say. The new approach specifically examines DNA samples from vaginal secretions for the presence of chemical “off” switches — known as methylation — that can disable genes that normally keep cancer in check.
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say scientists.
A substantial gap exists between patient expectations and current practices for providing information about medical imaging tests that use radiation, according to a new study. Researchers said the findings highlight a need for better communication as medicine enters an era of patient-centered care.
A new approach to treating B cell acute lymphoblastic leukaemia has been uncovered by researchers. B cell acute lymphoblastic leukaemia, or B-ALL, is the most common tumor disease in children and also occurs in adults. It develops when signalling pathways in immature B cells, or pre-B cells, are dysregulated. These studies could change the way we think about clinical therapies for treating these tumor diseases, authors say.
Tambahkan Komentar